DNMT inhibitors offer a promising approach to reverse these epigenetic alterations and restore the expression of silenced genes, ultimately inhibiting tumor growth and sensitizing TNBC cells to conventional chemotherapeutic agents and targeted therapies. Here, DNMT1 is linked to neoplasm.